Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details) - Schedule of Common Share Equivalents and Potentially Dilutive Securities

v3.24.2.u1
Summary of Significant Accounting Policies (Details) - Schedule of Common Share Equivalents and Potentially Dilutive Securities - shares
 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Schedule of Common Share Equivalents and Potentially Dilutive Securities [Line Items]    
Diluted common shares outstanding 2,068,924,169 1,898,769,195
Warrants [Member]    
Schedule of Common Share Equivalents and Potentially Dilutive Securities [Line Items]    
Diluted common shares outstanding 33,400,000 34,000,000
Series B preferred stock [Member]    
Schedule of Common Share Equivalents and Potentially Dilutive Securities [Line Items]    
Diluted common shares outstanding 357,819,360 324,240,164
Series C preferred stock [Member]    
Schedule of Common Share Equivalents and Potentially Dilutive Securities [Line Items]    
Diluted common shares outstanding 450,258,000 386,250,000
Convertible debt [Member]    
Schedule of Common Share Equivalents and Potentially Dilutive Securities [Line Items]    
Diluted common shares outstanding 1,220,101,111 1,145,833,333
Stock options [Member]    
Schedule of Common Share Equivalents and Potentially Dilutive Securities [Line Items]    
Diluted common shares outstanding 7,345,698 8,445,698